Allergan, the maker of the Botox anti-wrinkle treatment, said its Q4 earnings rose. Allergan CEODavid Pyott talks with Mad Money host Jim Cramer.
CNBC's Seema Mody reports on some big movers at the Nasdaq.
Oct 12- Watson Pharmaceuticals Inc:. *Watson's generic sanctura xrï¿ ½ receives FDA approval. *Says intends to begin shipping the product immediately.
*Nomura cuts Aegon to neutral from buy For a summary of rating actions and price target changes on European companies:. Reuters Eikon users, click on. Reuters Station users, click. 1580.
--We based our opinion of AEGON's primary servicing operation on the company's long, successful track record servicing multifamily/commercial real estate loans primarily originated for life insurance companies, experienced management team, good leverage of technology, and sound control environment.